Jun-15-19
A microfluidic sensor that tracks the progress of sickle cell through electrical impedance offers a quick and easy way to monitor the disease.
Developed by a team from Florida Atlantic University, the microfluidic chip helps clinicians monitor the progress of the unpredictable disease by exposing the patient’s blood sample to high and low levels of oxygen. This causes the cells to sickle and unsickle, the rate of which can be measured using electrical impedance detection. That data can then be used by clinicians to determine disease severity, blood vessel blockage risk and assess how well treatments are working.
Show 1 Comment